Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists

被引：7
|
作者：
Meynaar, Iwan A. [1 ]
van Rijn, Simone [2 ]
Ottens, Thomas H. [1 ]
van Burgel, Nathalie D. [3 ]
van Nieuwkoop, Cees [4 ]
机构：
[1] Haga Teaching Hosp, Dept Intens Care, The Hague, Netherlands
[2] Haga Teaching Hosp, Dept Infect Prevent & Control, The Hague, Netherlands
[3] Haga Teaching Hosp, Dept Microbiol, The Hague, Netherlands
[4] Haga Teaching Hosp, Dept Internal Med, The Hague, Netherlands
来源：
INTENSIVE CARE MEDICINE | 2022年 / 48卷 / 07期
关键词：
D O I：
10.1007/s00134-022-06750-w
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：954 / 957
页数：4
相关论文
共 50 条
  • [1] Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists
    Iwan A. Meynaar
    Simone van Rijn
    Thomas H. Ottens
    Nathalie D. van Burgel
    Cees van Nieuwkoop
    [J]. Intensive Care Medicine, 2022, 48 : 954 - 957
  • [2] Central line-associated bloodstream infections in patients with COVID-19
    Acosta, Nicole Caetano
    Ceratti, Rodrigo do Nascimento
    Santos, Marina Scherer
    Fantin, Simone de Souza
    Fuzinatto, Fernanda
    Neto, Omar Pereira de Almeida
    Rabelo-Silva, Eneida Rejane
    [J]. REVISTA LATINO-AMERICANA DE ENFERMAGEM, 2024, 32
  • [3] Central line-associated bloodstream infections in hemodialysis patients in the COVID-19 era
    Esposito, Pasquale
    Civati, Alessandra
    Picciotto, Daniela
    Falqui, Valeria
    Conti, Novella
    Russo, Elisa
    Viazzi, Francesca
    [J]. HEMODIALYSIS INTERNATIONAL, 2021, 25 (02) : 275 - 278
  • [4] COVID-19 AND CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTION: A SINGLE TERTIARY CENTER EXPERIENCE
    Vazquez, Daniel
    Horattas, Illeana
    Krizo, Jessica
    Mallat, Ali
    Vazquez, Kaitlin
    Schweibinz, Alexis
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 95 - 95
  • [5] Central Venous Catheter Repair Is Associated With an Increased Risk of Bacteremia and Central Line-associated Bloodstream Infection in Pediatric Patients
    Lundgren, Ingrid S.
    Zhou, Chuan
    Malone, Frances R.
    Mcafee, Nancy G.
    Gantt, Soren
    Zerr, Danielle M.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (04) : 337 - 340
  • [6] RISK FACTORS FOR CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTION IN PEDIATRIC ONCOLOGY PATIENTS
    Kelly, Matthew
    Conway, Margaret
    Wirth, Kathleen
    Billett, Amy
    Sandora, Thomas
    [J]. PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 823 - 824
  • [7] Effects of COVID-19 hospitalization rates on the incidence of hospitalacquired Candida central line-associated bloodstream infection
    Ford, Delvina
    Reveles, Kelly
    Hoban, Carol
    Koutoubi, Samer
    Cadena, Jose
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2024, 52 (04) : 387 - 391
  • [8] Central line-associated bloodstream infection prevention
    Miller, Sarah E.
    Maragakis, Lisa L.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (04) : 412 - 422
  • [9] Racial disparities in central line-associated bloodstream infections: the impact of the COVID-19 pandemic
    DeWitt, Michael E.
    Sampson, Mindy M.
    Kester, Shelley
    MacNeill, Emily
    Passaretti, Catherine
    [J]. INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2024,
  • [10] Zero risk for central line-associated bloodstream infection: Are we there yet?
    McLaws, Mary-Louise
    Burrell, Anthony R.
    [J]. CRITICAL CARE MEDICINE, 2012, 40 (02) : 388 - 393
12345